Browsing by Author Barter, Philip

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 130  next >
Issue DateTitleAuthor(s)Citation
2010The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro.Barter, Philip; Rye, Kerry-Anne; Lambert, Gilles; Millet, Jonathon; Nakhla, Shirley; Remaley, Alan; Segaliny, Aude; Tabet, Fatiha; Yan, Ling; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research InstituteThe 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro., Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, 2,pp 246-252
2010Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetesBarter, Philip; Keech, Anthony (Tony); Mann, Kirsty; Simes, Robert John; Best, J; Ehnholm, Christian; Hamwood, S; Sullivan, David Richmond; Taskinen, M.; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAbility of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes, Diabetologia: clinical and experimental diabetes and metabolism, vol.53, 9,pp 1846-1855
2007Abstract 1047: Infusion of Reconstituted High Density Lipoproteins Into Humans Enhances the In Vitro Anti-Inflammatory Capacity of the High Density Lipoprotein FractionBarter, Philip; Celermajer, David; Patel, Sanjay; Rye, Kerry-Anne; Drew, Brian; Duffy, Stephen; Kingwell, Bronwyn; Nahkla, Shirley; Central Clinical School: Heart Research Institute; Central Clinical School: Medicine; Medicine Faculty Office; Central Clinical School: Heart Research InstituteAbstract 1047: Infusion of Reconstituted High Density Lipoproteins Into Humans Enhances the In Vitro Anti-Inflammatory Capacity of the High Density Lipoprotein Fraction, Circulation (Baltimore), vol.116, N/A,pp II_209-N/A
2006Abstract 1355: The Impact of Glycation on the Anti-inflammatory Properties of High Density Lipoproteins in vivoBao, Shisan; Barter, Philip; Celermajer, David; Davies, Michael; Puranik, Rajesh; Rye, Kerry-Anne; Nobecourt, Estelle; School of Medical Sciences: Pathology; Central Clinical School: Heart Research Institute; Central Clinical School: Medicine; Central Clinical School: Heart Research Institute; Central Clinical School: Medicine; Central Clinical School: Heart Research InstituteAbstract 1355: The Impact of Glycation on the Anti-inflammatory Properties of High Density Lipoproteins in vivo, Circulation (Baltimore), vol.114, N/A,pp II-257-II-258
2006Abstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) TrialsBarter, Philip; Cater, Nilo B; Demicco, David A; Gaffney, Michael; Holme, Ingar; Kastelein, John J.P.; LaRosa, John C.; Olsson, Anders G; Pedersen, Terje R; Szarek, M; Central Clinical School: Heart Research InstituteAbstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) Trials, Circulation (Baltimore), vol.114, N/A,pp II_713-II_714
2007Abstract 3691: Features Of Metabolic Syndrome Identify Individuals With Type 2 Diabetes Mellitus At High Risk For Cardiovascular Events And Greater Absolute Benefits Of FenofibrateBarter, Philip; Copt, Samuel; Keech, Anthony (Tony); Pardy, Christopher; Best, James; D'Emden, Michael C.; Drury, P; Ehnholm, Christian; FIELD study investigators, Fenofibrate Intervention and Event Lowering in Diabetes; Kesaniemi, Y. Antero; Scott, Russell; Taskinen, M.; Tse, Dana; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAbstract 3691: Features Of Metabolic Syndrome Identify Individuals With Type 2 Diabetes Mellitus At High Risk For Cardiovascular Events And Greater Absolute Benefits Of Fenofibrate, Circulation (Baltimore), vol.116, N/A,pp II_838-N/A
2009Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteinsBarter, Philip; Celermajer, David; Patel, Sanjay; Puranik, Rajesh; Rye, Kerry-Anne; Stocker, Roland; Wang, Xiaosuo; Lambert, Gilles; Lundmand, Pia; Nakhla, Shirley; Nicholls, Stephen J; Central Clinical School: Heart Research Institute; Central Clinical School: Medicine; Medicine Faculty Office; Central Clinical School: Medicine; Other or Unknown; School of Medical Sciences: Pathology; School of Medical Sciences: Bosch InstituteAcute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins, Atherosclerosis, vol.204, 2, 2009,pp 424-428
2006Aggressive lipid lowering with atorvastatin reduces increased risk of cardiovascular events in patients with metabolic syndrome and coronary heart diseaseBarter, Philip; Carmena, Rafael; Deedwania, Prakash; Fruchart, Jean-Charles; Haffner, Steven; Shepherd, James; Treating to New Targets, (TNT) Investigators; Central Clinical School: Heart Research InstituteAggressive lipid lowering with atorvastatin reduces increased risk of cardiovascular events in patients with metabolic syndrome and coronary heart disease, European Heart Journal (English Edition), vol.27, Suppl 1,pp 931-932
2010Anti-inflammatory effects of apolipoprotein A-I in the rabbitBarter, Philip; Celermajer, David; Patel, Sanjay; Rye, Kerry-Anne; Di Bartolo, Belinda; Heather, Alison K; Jessup, Wendy; Mitchell, Todd; Nakhla, Shirley; Central Clinical School: Heart Research Institute; Central Clinical School: Medicine; Medicine Faculty Office; Central Clinical School: Heart Research InstituteAnti-inflammatory effects of apolipoprotein A-I in the rabbit, Atherosclerosis, vol.212, 2,pp 392-397
2005Antiatherogenic Properties of FibratesBarter, Philip; Central Clinical School: Heart Research InstituteAntiatherogenic Properties of Fibrates, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, 6,pp 1095-1096
2004Antiinflammatory Properties Of Hdl.Barter, Philip; Nicholls, Stephen; Rye, Kerry-Anne; Anantharamaiah, G M; Fogelman, Alan M; Navab, Mohamad; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Heart Research InstituteAntiinflammatory Properties Of Hdl., Circulation Research, vol.95,(8),2004,pp 764-772
2006Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.Barter, Philip; Ballantyne, C. M.; Carmena, Rafael; Castro Cabezas, M.; Chapman, M. John; Couture, Patrick; De Graaf, J.; Durrington, P. N.; et, al; Faergeman, O.; Frohlich, J; Central Clinical School: MedicineApo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel., Journal of Internal Medicine, vol.259,(3),2006,pp 247-258
2012ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE StudiesBarter, Philip; Ballantyne, C. M.; Borgman, Marilyn; Brewer, H Bryan; Gordon, Allan; Johannson, Jan; Kastelein, John J.P.; Nicholls, Stephen J; Nissen, Steven; Wong, Norman; Central Clinical School: Heart Research InstituteApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies, Cardiovascular Drugs and Therapy, vol.26, 2, 2012,pp 181-187
2008Apolipoprotein A-I and Reconstituted High-Density Lipoproteins Inhibit NADPH Oxidase Activation and Expression and Increase Superoxide Dismutase Levels in Human Macrophages in High Glucose ConditionsBarter, Philip; Rye, Kerry-Anne; Tabet, Fatiha; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research InstituteApolipoprotein A-I and Reconstituted High-Density Lipoproteins Inhibit NADPH Oxidase Activation and Expression and Increase Superoxide Dismutase Levels in Human Macrophages in High Glucose Conditions, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, 6,pp e-87-N/A
2014Apolipoprotein a-I increases Insulin Secretion and Production from Pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1- Dependent MechanismBarter, Philip; Rye, Kerry-Anne; Bisoendial, Radjesh; Cochrane, Blake; Glaros, Elias N; Hou, Liming; Rossy, Jérémie; Thomas, Shane R.; Central Clinical School: Heart Research Institute; Other or UnknownApolipoprotein a-I increases Insulin Secretion and Production from Pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1- Dependent Mechanism, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.34, 10, 2014,pp 2261-2267
2015Apolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on LymphangiogenesisBarter, Philip; Cook, Adam; Rye, Kerry-Anne; Weninger, Wolfgang; Bisoendial, Radjesh; Hou, Liming; Petrides, Francine; Tabet, Fatiha; Tak, Paul P; Torres, Luisa F. Cuesta; Central Clinical School: Heart Research Institute; Central Clinical School: Centenary Institute; Other or Unknown; Central Clinical School: Centenary InstituteApolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on Lymphangiogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.35, 11, 2015,pp 2443-2450
2011The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteinsBao, Shisan (Bob); Barter, Philip; Bursill, Christina; Heather, Alison; Rye, Kerry-Anne; Di Bartolo, Belinda; Nicholls, Stephen J; School of Medical Sciences: Pathology; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Central Clinical School: Medicine; Central Clinical School: Heart Research InstituteThe apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins, Atherosclerosis, vol.217, 2, 2011,pp 395-400
2011The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbitBao, Shisan (Bob); Barter, Philip; Bursill, Christina; Rye, Kerry-Anne; Di Bartolo, Belinda; Tan, Joanne; Vanags, Laura; School of Medical Sciences: Pathology; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research InstituteThe apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit, Lipids in Health and Disease, vol.10, N/A, 2011,pp Article no. 224 - 1-Article no. 224 - 8
2004Apolipoprotein E Enhances Hepatic Lipase-Mediated Hydrolysis Of Reconstituted High-Density Lipoprotein Phospholipid And Triacylglycerol In An Isoform-Dependent Manner.Barter, Philip; Rye, Kerry-Anne; Drew, Kate J; Hahn, Chris; Hime, Neil J; Central Clinical School: Medicine; Central Clinical School: Heart Research InstituteApolipoprotein E Enhances Hepatic Lipase-Mediated Hydrolysis Of Reconstituted High-Density Lipoprotein Phospholipid And Triacylglycerol In An Isoform-Dependent Manner., Biochemistry 2005, vol.43,(38),2004,pp 12306-12314
2003Apolipoprotein-A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formationBarter, Philip; Bonnet, David J.; Curtiss, Linda K.; Rye, Kerry-Anne; Wee, Kevin; Central Clinical School: MedicineApolipoprotein-A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation, Journal of Biological Chemistry, vol.278,(25),2003,pp 22530-22536